Announcements Trials
Browse Landscape

Phase

Phase 2 80Phase 3 47Phase 1/2 23Phase 1 22Phase 2/3 4Phase EARLY_PHASE1 3Phase 4 3Phase NA 1

Status

Completed 32Unknown 12Terminated 5Recruiting 4Withdrawn 3Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Neoplasms 1Multiple Myeloma 1

Interventions

Standard of Care 41Methods 37Practice Guidelines as Topic 36Exercise 36Educational Status 36Surveys and Questionnaires 33Early Intervention, Educational 32Radiotherapy 25Radiosurgery 24Magnetic Resonance Spectroscopy 23Interviews as Topic 20Blood Specimen Collection 17Surgical Procedures, Operative 14Radiotherapy, Intensity-Modulated 12Counseling 12Radiation 11Palliative Care 11Nutrition Assessment 11Specimen Handling 9Resistance Training 9Proton Therapy 8Mammography 8Biopsy 8Yoga 7Radiofrequency Ablation 7Drug Therapy 7Diet Therapy 7Control Groups 7Referral and Consultation 6Radiation Dose Hypofractionation 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Active not recruiting × Dexamethasone × Clear all
NCT06924424 2025-04-11

Aponermin, Pomalidomide, Dexamethasone for Patients With Relapsed/ Refractory Multiple Myeloma

Peking University People's Hospital

Phase NA Active not recruiting
105 enrolled
Plasma cell

Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡